COMPANY
Nemalife Inc.
NIH awards 6
- NIH award 1R43AT012449-01A1 FY2024: $295,780 awarded for that fiscal year; activity R43 (SBIR); PI QURESHI, MOHAMMED ADNAN MOHAMMED HANIF; recipient as written: NEMALIFE INC., LUBBOCK, TX. Development of a high throu source ↗
- NIH award 1R43AA031342-01A1 FY2024: $322,070 awarded for that fiscal year; activity R43 (SBIR); PI QURESHI, MOHAMMED ADNAN MOHAMMED HANIF; recipient as written: NEMALIFE INC., LUBBOCK, TX. Development of an AI-assist source ↗
- NIH award 1R43AG078715-01 FY2022: $398,019 awarded for that fiscal year; activity R43 (SBIR); PI RAHMAN, MIZANUR; recipient as written: NEMALIFE INC., LUBBOCK, TX. High throughput functional screening of anti-sarcope source ↗
- NIH award 1R43DA056089-01 FY2022: $318,373 awarded for that fiscal year; activity R43 (SBIR); PI PATEL, DHAVAL SUBHAS; recipient as written: NEMALIFE INC., LUBBOCK, TX. AI-assisted behavioral profiling of an inverteb source ↗
- NIH award 1R43ES032516-01 FY2021: $251,040 awarded for that fiscal year; activity R43 (SBIR); PI TOTH, MARTON; recipient as written: NEMALIFE INC., LUBBOCK, TX. A novel technology to assess chronic toxicity in geneti source ↗
- NIH award 1R43AG071142-01 FY2021: $348,285 awarded for that fiscal year; activity R43 (SBIR); PI TOTH, MARTON; recipient as written: NEMALIFE INC., LUBBOCK, TX. High-throughput testing of anti-aging and FDA approved source ↗